Amazon has filed a WARN notice indicating it will permanently eliminate 2,198 positions across multiple locations in Washington state by late April 2026, adding to a wave of corporate restructuring that has already seen thousands of layoffs in the region.
Nearly half of U.S. employers are shifting from merit-based raises to flat, across-the-board pay increases—a move that could provide crucial relief for lower-wage workers amid economic uncertainty.
Canopy Growth's shares have plummeted over 99% in five years, yet analysts warn its challenges run deeper than its stock price suggests. Despite recent U.S. regulatory changes, structural industry headwinds and the company's own track record make it a speculative play at best.
As the energy sector leads the market in early 2026, ConocoPhillips and Kinder Morgan emerge as compelling picks for investors seeking reliable, growing dividends backed by strong fundamentals and strategic positioning.
Amid a volatile market for mining stocks, Ramelius Resources stands out with a consistently high Return on Capital Employed (ROCE) of 30%, significantly outpacing its industry peers and fueling its multi-bagger potential.
As economic anxieties mount, strategic diversification remains paramount. We examine two Vanguard ETFs that could offer stability and long-term growth opportunities should market conditions deteriorate.
The severe winter storm Fern, leaving nearly a million customers without power, has starkly highlighted the U.S. electrical grid's persistent vulnerabilities. This comes despite repeated warnings from reliability monitors about the system's growing strain.
As Microsoft shares trade nearly 12% below recent highs, some analysts see a buying opportunity. We explore how selling put options could offer investors a strategic entry point while generating income.
Clinical-stage biotech Erasca (ERAS) has seen its stock skyrocket over the past 12 months, hitting a multi-year high. While technical momentum is strong, the company remains pre-revenue, with its fate tied to future drug approvals, presenting a classic high-risk, high-reward scenario for investors.
Fifth Third Bancorp has finalized its acquisition of Comerica Incorporated, a move that consolidates the Midwest banking landscape and creates the nation's ninth-largest bank with nearly $300 billion in assets.
While the S&P 500 remains a core holding for many, actively managed and thematic ETFs offer a path to potentially superior returns. We analyze three Fidelity funds with distinct strategies—from U.S. tech dominance to international dividend income—that have historically beaten the market.
In an unusual acquisition within the ETF space, the investment arm behind former President Donald Trump's social media platform is set to purchase the conservative-themed 'God Bless America' ETF, significantly expanding its asset base and adding active management to its lineup.
Asset managers unleashed a historic wave of nearly 1,000 new active ETFs last year, even as a record number shuttered. Despite the high-stakes environment, firms are doubling down, betting on sustained investor demand and advisor adoption to justify the rush.
PLS Group (ASX:PLS) receives significant forecast upgrades from analysts, with revenue projections for 2026 raised to AU$1.6b and the company expected to return to profitability this year.
Novo Nordisk launches its first oral GLP-1 weight-loss drug with strong early demand, reports positive Phase 3 results for CagriSema, and expands a cell therapy partnership for diabetes. These moves come as investors reevaluate the company's long-term growth prospects amid competitive and pricing pressures.
A company linked to a key UAE national security adviser, Sheikh Tahnoon bin Zayed Al Nahyan, secured a 49% equity stake in World Liberty Financial, the Trump family's flagship crypto firm, just days before President Trump's 2025 inauguration. The investment raises fresh questions about the intersection of foreign capital, presidential family businesses, and U.S. policy.
CNBC's Jim Cramer highlighted International Business Machines Corp. (IBM) as a standout AI investment with a relatively modest valuation, following a robust quarterly report that sent shares soaring.
CNBC's Jim Cramer positions Alphabet as the potential 'only winner in AI,' suggesting its upcoming earnings may show it generating more revenue from AI than rival Meta Platforms.
CNBC's Jim Cramer suggests investors watch for a pullback in Microsoft shares, praising its leadership but expressing concern that the tech giant's AI investments may not be optimally targeted to meet soaring demand.
CNBC's Jim Cramer tempered enthusiasm for Novo Nordisk stock, suggesting investors hold rather than buy after its massive gains driven by blockbuster weight-loss drugs.
